Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2012
10/25/2012US20120270821 CDK5 Inhibitors and Therapeutic Uses Thereof
10/25/2012US20120270820 Use of albiflorin for anti-depression
10/25/2012US20120270816 Methods of diagnosing and treating migraine
10/25/2012US20120270809 Human transmembrane proteins
10/25/2012US20120270795 Compounds for the treatment of diseases related to protein misfolding
10/25/2012US20120270794 Polymorphisms associated with parkinson's disease
10/25/2012US20120270792 Urocortin-iii and uses thereof
10/25/2012US20120270785 Therapy and Prevention of Problem Drinking
10/25/2012US20120270783 Rapid opioid detoxification
10/25/2012US20120270779 Dosing regimens for neural stem cell proliferating agents and differentiating agents for the treatment of neurological disorders
10/25/2012US20120270777 Lactoferrin and gut neuronal health in adults and/or elderly
10/25/2012US20120270771 Apolipoprotein a-1 mimic peptides, and therapeutic agent for treating hyperlipidemia and diseases related to hyperlipidemia comprising same
10/25/2012US20120270770 Anti-angiogenic peptides and their uses
10/25/2012US20120270766 Early programming of brain function through soy protein feeding
10/25/2012US20120269909 Preparation comprising amino acids and plants and its activity in the alcohol detoxification
10/25/2012US20120269906 Treatment of suicidal ideation or behavior using inhibitors of nicotinic acetylcholine receptors
10/25/2012US20120269881 Transdermal drug delivery device including an occlusive backing
10/25/2012US20120269871 Solid state forms of rasagiline salts
10/25/2012US20120269868 Compositions and methods for nutritional supplementation
10/25/2012US20120269867 Methods of treating central nervous system tumors
10/25/2012US20120269865 Nutritional composition for promoting gut microbiota balance and health
10/25/2012US20120269864 Arginine Derivatives with NP-I Antagonistic Activity
10/25/2012US20120269838 Carrier conjugates of il-23-peptides and their induced antibodies
10/25/2012US20120269831 Substituted pyrido[2,3-d]pyrimidin-7(8h)-ones and therapeutic uses thereof
10/25/2012US20120269829 Inhibitors of Phosphatase and Tensin Homolog (PTEN) Compositions, Uses and Methods
10/25/2012US20120269828 Anti-drug vaccines
10/25/2012US20120269822 Anti-Botulinum Neurotoxin a Single Domain Antibody Antibodies
10/25/2012US20120269820 Anti-il 17a/il-17f cross-reactive antibodies and methods of use thereof
10/25/2012US20120269815 Neurotrophins and uses thereof
10/25/2012US20120269810 Methods and compositions for panic disorders
10/25/2012US20120269808 Methods and compositions for modulating tweak and fn14 activity
10/25/2012US20120269807 COMPOSITIONS AND METHODS FOR BLOOD-BRAIN BARRIER DELIVERY OF lgG-DECOY RECEPTOR FUSION PROTEINS
10/25/2012US20120269805 Antibodies directed against amyloid-beta peptide and methods using same
10/25/2012US20120269799 Diagnostic and treatment methods using a ligand library
10/25/2012US20120269797 Method for inhibiting the maturation of dendritic cells
10/25/2012US20120269794 Nutraceutical composition that comprises extract of shilajit, folic acid, vitamin b12 and vitamin b6 and the use thereof for preventing and/or treating neurodegenerative diseases and/or the cognitive deterioration associated with cerebral ageing
10/25/2012US20120269787 Systemic, allogenic stem cell therapies for treatment of diseases in equines
10/25/2012US20120269786 Systemic, allogenic stem cell therapies for treatment of diseases in felines
10/25/2012US20120269785 Systemic, allogenic stem cell therapies for treatment of diseases in canines
10/25/2012US20120269778 Methods of generating neural stem cells
10/25/2012US20120269772 Lipid depot formulations
10/25/2012US20120269767 Treatment of Neurodegenerative Diseases
10/25/2012US20120269765 Cytokine compositions and methods of use thereof
10/25/2012US20120269762 Causal therapy of diseases or conditions associated with cns or pns demyelination
10/25/2012US20120269738 Imaging Beta-Amyloid Peptides and Inhibition of Beta-Amyloid Peptide Aggregation
10/25/2012US20120269726 Heterodimers of Glutamic Acid
10/24/2012EP2514824A2 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
10/24/2012EP2514823A2 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
10/24/2012EP2514753A1 6,7-Dihydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivatives and pharmaceutical compositions containing the same as hypnotic or anesthetic agent and method for their preparation
10/24/2012EP2514752A1 Epothilone compounds, preparation method and use thereof
10/24/2012EP2514751A1 Azaindazoles useful as inhibitor of kinases
10/24/2012EP2514747A1 Substituted aminothiazine derivative
10/24/2012EP2514417A2 Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disorders, or attention deficit disorders
10/24/2012EP2514416A1 Transdermally absorbed preparation of anti-dementia drug
10/24/2012EP2514415A1 Transdermally absorbed preparation of anti-dementia drug
10/24/2012EP2514414A1 Transdermally absorbed preparation of anti-dementia drug
10/24/2012EP2513121A1 Prostate specific membrane antigen inhibitors
10/24/2012EP2513117A1 Bicyclic thiazoles as allosteric modulators of mglur5 receptors
10/24/2012EP2513111A1 Mk2 inhibitors
10/24/2012EP2513107A1 Heteroaromatic phenylimidazole derivatives as pde10a enzyme inhibitors
10/24/2012EP2513106A1 Heteroaromatic aryl triazole derivatives as pde10a enzyme inhibitors
10/24/2012EP2513105A1 2-arylimidazole derivatives as pde10a enzyme inhibitors
10/24/2012EP2513102A1 Ethynyl derivatives
10/24/2012EP2513097A1 Diazabicyclononyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators
10/24/2012EP2513090A1 Compound suitable for the treatment of synucleopathies
10/24/2012EP2513088A1 Novel (heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors
10/24/2012EP2513085A1 BICYCLIC COMPOUNDS AS alpha4beta2 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
10/24/2012EP2513084A1 Pyrrolidine derivatives as nk - 3 receptor antagonists
10/24/2012EP2513072A1 Pyrazine derivatives,process for manufacture and use thereof
10/24/2012EP2513062A1 7-chloro-quinolin-4-amine compounds and uses thereof for the prevention or treatment of diseases involving formation of amyloid plaques and/or where a dysfunction of the app metabolism occurs
10/24/2012EP2513061A1 Pyridone derivatives as nk3 antagonists
10/24/2012EP2513052A1 Pyrrolidine derivatives
10/24/2012EP2512522A2 Particles for multiple agent delivery
10/24/2012EP2512514A1 Pharmaceutical composition for prevention and treatment of amyotrophic lateral sclerosis
10/24/2012EP2512499A1 Use of a neurofilament peptide for the treatment of glioma
10/24/2012EP2512470A1 Ppar-sparing thiazolidinediones and combinations for the treatment of neurodegenerative diseases
10/24/2012EP2512245A1 Pyridoquinazolinone m1 receptor positive allosteric modulators
10/24/2012EP2512243A1 Quinoline amide m1 receptor positive allosteric modulators
10/24/2012EP2512242A1 Novel compounds
10/24/2012EP2512241A1 Compounds for the treatment of neurologic disorders
10/24/2012CN102753690A Compositions and methods for re-programming cells without genetic modification for treatment of neurological disorders
10/24/2012CN102753552A Novel benzoic pyrrolopyridine derivatives
10/24/2012CN102753551A 2-arylimidazole derivatives as pde10a enzyme inhibitors
10/24/2012CN102753550A Heteroaromatic aryl triazole derivatives as pde10a enzyme inhibitors
10/24/2012CN102753541A Carboxamide compounds and their use as calpain inhibitors iv
10/24/2012CN102753540A A4ss2 neuronal nicotinic acetylcholine receptor ligands
10/24/2012CN102753533A Imidazolidinedione derivatives
10/24/2012CN102753181A A pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility properties
10/24/2012CN102753172A 5-HT4 receptor agonists for the treatment of dementia
10/24/2012CN102753171A Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide
10/24/2012CN102753169A Topical transdermal dexmedetomidine compositions and methods of use thereof
10/24/2012CN102753159A Pharmaceutical composition comprising propofol
10/24/2012CN102753158A Transdermally absorbed preparation of anti-dementia drug
10/24/2012CN102753155A 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates
10/24/2012CN102753154A 4-[2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine salts
10/24/2012CN102749413A Quality detection method of traditional Chinese medicine composition for treating headache
10/24/2012CN102746325A Compound 1,10-N-decylene lycorine dibromo salt, pharmaceutical composition and application thereof in medicine
10/24/2012CN102746301A 8-phenyl-7,8-dihydropyrido[2,3-d]pyrimidin-7-ones and their use as pharmaceuticals
10/24/2012CN102746300A 8-phenyl-7,8-dihydropyridines[2,3-d]pyrimidine-7-ketone and uses as medicament
10/24/2012CN102746299A 8-PHENYL-7,8-DIHYDROPYRIDO[2,3-d]PYRIMIDIN-7-ONES AND THEIR USE AS PHARMACEUTICALS
1 ... 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 ... 1833